VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Amgen Inc. vs Koninklijke Philips N.V.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Koninklijke Philips N.V.
PHIA · Euronext Amsterdam
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Koninklijke Philips N.V.'s moat claims, evidence, and risks.
View PHIA analysisComparison highlights
- Moat score gap: Amgen Inc. leads (70 / 100 vs 68 / 100 for Koninklijke Philips N.V.).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Koninklijke Philips N.V. has 3 segments (48.9% in Diagnosis & Treatment).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Koninklijke Philips N.V. has 6 across 3.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Koninklijke Philips N.V.
Diagnosis & Treatment
Medical imaging, image-guided therapy systems, and enterprise imaging informatics
Global
Hospitals & clinics
OEM systems + software + services
48.9%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
Koninklijke Philips N.V. strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Koninklijke Philips N.V. segments
Full profile >Diagnosis & Treatment
Oligopoly
Connected Care
Oligopoly
Personal Health
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.